ENZOIMMUNE ACTIVE IMMUNE MODULATOR Trademark

Trademark Overview

On Tuesday, June 8, 2021, a trademark application was filed for ENZOIMMUNE ACTIVE IMMUNE MODULATOR with the United States Patent and Trademark Office. The USPTO has given the ENZOIMMUNE ACTIVE IMMUNE MODULATOR trademark a serial number of 79318949. The federal status of this trademark filing is REGISTERED as of Tuesday, July 12, 2022. This trademark is owned by Rosetta Lifecare Bulgaria. The ENZOIMMUNE ACTIVE IMMUNE MODULATOR trademark is filed in the Pharmaceutical Products category with the following description:

Vitamin supplements; food supplements; vitamin and mineral supplements; dietary and nutritional supplements; dietary and nutritional preparations in the nature of dietary and nutritional supplements for immune system support; dietary supplements for humans; pharmaceuticals for boosting the immune system; pharmaceutical compositions for support of the immune system
enzoimmune active immune modulator

General Information

Serial Number79318949
Word MarkENZOIMMUNE ACTIVE IMMUNE MODULATOR
Filing DateTuesday, June 8, 2021
Status700 - REGISTERED
Status DateTuesday, July 12, 2022
Registration Number6784215
Registration DateTuesday, July 12, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Description of MarkThe mark consists of the stacked wording "ENZOIMMUNE ACTIVE" in red with the wording "IMMUNE MODULATOR" in gray below. Beside the wording is a stylized design of two vertical blue shaded curved lines and two horizontal shaded blue lines going through the middle of the vertical lines.
Goods and ServicesVitamin supplements; food supplements; vitamin and mineral supplements; dietary and nutritional supplements; dietary and nutritional preparations in the nature of dietary and nutritional supplements for immune system support; dietary supplements for humans; pharmaceuticals for boosting the immune system; pharmaceutical compositions for support of the immune system
Indication of Colors claimedThe color(s) blue, red and grey is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"ACTIVE" AND "IMMUNE MODULATOR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRosetta Lifecare Bulgaria
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBG
Party NameRosetta Lifecare Bulgaria
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBG
Party NameRosetta Lifecare Bulgaria
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBG

Trademark Events

Event DateEvent Description
Thursday, July 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 27, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 27, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 14, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 21, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 21, 2022FINAL DISPOSITION PROCESSED
Wednesday, October 12, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 12, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 12, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 3, 2022NOTIFICATION PROCESSED BY IB
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Sunday, April 24, 2022REFUSAL PROCESSED BY IB
Wednesday, April 13, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 13, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 6, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 6, 2022REFUSAL PROCESSED BY MPU
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 8, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 7, 2022NON-FINAL ACTION WRITTEN
Friday, February 25, 2022ASSIGNED TO EXAMINER
Wednesday, October 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 27, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, October 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 7, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, September 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 27, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

modulator immune active enzoimmune supplements dietary system nutritional support vitamin boosting compositions pharmaceutical